Literature DB >> 32140209

Portal Hypertension and Cirrhosis: From Evolving Concepts to Better Therapies.

Jaume Bosch1,2,3.   

Abstract

Entities:  

Year:  2020        PMID: 32140209      PMCID: PMC7050946          DOI: 10.1002/cld.844

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN: 2046-2484


× No keyword cloud information.
  27 in total

1.  Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2005-07       Impact factor: 25.083

2.  Beta-blockers in 2016: Still the safest and most useful drugs for portal hypertension?

Authors:  Gennaro D'Amico; Giuseppe Malizia; Jaime Bosch
Journal:  Hepatology       Date:  2016-03-22       Impact factor: 17.425

3.  Early use of TIPS in patients with cirrhosis and variceal bleeding.

Authors:  Juan Carlos García-Pagán; Karel Caca; Christophe Bureau; Wim Laleman; Beate Appenrodt; Angelo Luca; Juan G Abraldes; Frederik Nevens; Jean Pierre Vinel; Joachim Mössner; Jaime Bosch
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

Review 4.  Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments.

Authors:  Jaume Bosch; Roberto J Groszmann; Vijay H Shah
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

5.  Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators.

Authors:  P S Bhathal; H J Grossman
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

6.  Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.

Authors:  Dinesh Mani Tripathi; Marina Vilaseca; Erica Lafoz; Héctor Garcia-Calderó; Gabriela Viegas Haute; Anabel Fernández-Iglesias; Jarbas Rodrigues de Oliveira; Juan Carlos García-Pagán; Jaime Bosch; Jordi Gracia-Sancho
Journal:  Gastroenterology       Date:  2018-07-25       Impact factor: 22.682

7.  Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells.

Authors:  Jonel Trebicka; Martin Hennenberg; Margarete Odenthal; Khanwali Shir; Sabine Klein; Michaela Granzow; Annabelle Vogt; Hans-Peter Dienes; Frank Lammert; Jürg Reichen; Jörg Heller; Tilman Sauerbruch
Journal:  J Hepatol       Date:  2010-06-18       Impact factor: 25.083

8.  Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial.

Authors:  Àngels Escorsell; Oana Pavel; Andrés Cárdenas; Rosa Morillas; Elba Llop; Càndid Villanueva; Juan C Garcia-Pagán; Jaime Bosch
Journal:  Hepatology       Date:  2016-01-14       Impact factor: 17.425

9.  Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study.

Authors:  Virginia Hernández-Gea; Bogdan Procopet; Álvaro Giráldez; Lucio Amitrano; Candid Villanueva; Dominique Thabut; Luis Ibañez-Samaniego; Gilberto Silva-Junior; Javier Martinez; Joan Genescà; Christophe Bureau; Jonel Trebicka; Elba Llop; Wim Laleman; Jose Maria Palazon; Jose Castellote; Susana Rodrigues; Lise L Gluud; Carlos Noronha Ferreira; Rafael Barcelo; Nuria Cañete; Manuel Rodríguez; Arnulf Ferlitsch; Jose Luis Mundi; Henning Gronbaek; Manuel Hernández-Guerra; Romano Sassatelli; Alessandra Dell'Era; Marco Senzolo; Juan G Abraldes; Manuel Romero-Gómez; Alexander Zipprich; Meritxell Casas; Helena Masnou; Massimo Primignani; Aleksander Krag; Frederik Nevens; Jose Luis Calleja; Christian Jansen; Marie Angèle Robic; Irene Conejo; Maria-Vega Catalina; Agustin Albillos; Marika Rudler; Edilmar Alvarado; Maria Anna Guardascione; Marcel Tantau; Jaime Bosch; Ferran Torres; Juan Carlos Garcia-Pagán
Journal:  Hepatology       Date:  2018-12-10       Impact factor: 17.425

10.  Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.

Authors:  Juan G Abraldes; Candid Villanueva; Carles Aracil; Juan Turnes; Manuel Hernandez-Guerra; Joan Genesca; Manuel Rodriguez; Jose Castellote; Juan Carlos García-Pagán; Ferran Torres; Jose Luis Calleja; Agustin Albillos; Jaime Bosch
Journal:  Gastroenterology       Date:  2016-01-14       Impact factor: 22.682

View more
  4 in total

Review 1.  Collaterals in portal hypertension: anatomy and clinical relevance.

Authors:  Hitoshi Maruyama; Shuichiro Shiina
Journal:  Quant Imaging Med Surg       Date:  2021-08

2.  Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells.

Authors:  Devaraj Ezhilarasan
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-13

3.  IGFBP-3: So Much More Than an IGF1/2 Binding Protein.

Authors:  Montserrat Marí
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-07-04

Review 4.  Efficacy of interventional radiology in the management of portal hypertension: A narrative review.

Authors:  Toru Ishikawa
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.